Unsupervised stratification of patients with myocardial infarction based on imaging and in-silico biomarkers

Serra, Dolors; Romero, Pau; Franco, Paula; Bernat, Ignacio; Lozano, Miguel; Garcia-Fernandez, Ignacio; Soto-Iglesias, David; Berruezo Sánchez, Antonio; Camara, Oscar; Sebastian, Rafael

doi:http://dx.doi.org/10.1109/TMI.2025.3582383

Unsupervised stratification of patients with myocardial infarction based on imaging and in-silico biomarkers

License

Citation

Serra D, Romero P, Franco P, Bernat I, Lozano M, Garcia-Fernandez I, et al. Unsupervised stratification of patients with myocardial infarction based on imaging and in-silico biomarkers. IEEE Trans Med Imaging. 2025 Dec;44(12):4762-74. DOI: 10.1109/TMI.2025.3582383

Abstract

This study presents a novel methodology for stratifying post-myocardial infarction patients at risk of ventricular arrhythmias using patient-specific 3D cardiac models derived from late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) images. The method integrates imaging and computational simulation with the fast electrophysiology solver, Arritmic3D, enabling rapid and accurate ventricular arrhythmias (VA) risk assessment in clinical timeframes. Applied to 51 patients, the solver generated thousands of personalized simulations exploring ranges of values for several parameters to evaluate arrhythmia inducibility and predict VA risk. Key findings include the identification of slow conduction channels (SCCs) within scar tissue as critical to reentrant arrhythmias and the localization of high-risk zones for potential intervention. The Arrhythmic Risk Score (ARRISK), developed from simulation results, demonstrated strong concordance with clinical outcomes and outperformed traditional imaging-based risk stratification. The methodology is fully automated, requiring minimal user intervention, and offers a promising tool for improving precision medicine in cardiac care by enhancing patient-specific arrhythmia risk assessment and guiding treatment strategies.